Cargando…
MAP0004 provided consistent migraine pain relief even after repeated administration
Autores principales: | Kori, S, Lu, B, Connors, E, Li, X, Kellerman, D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3620130/ http://dx.doi.org/10.1186/1129-2377-14-S1-P190 |
Ejemplares similares
-
Analysis of subjects with menstrually related migraine vs. Non-menstrually related migraine treated with MAP0004
por: Aurora, S, et al.
Publicado: (2013) -
Efficacy of MAP0004 in treating severe migraine
por: Kori, S, et al.
Publicado: (2013) -
Sustained pain relief with dihydroergotamine in migraine is potentially due to persistent binding to 5-HT1B and 5-HT1D receptors
por: Kori, S, et al.
Publicado: (2013) -
Eletriptan provides consistent migraine relief: results of a within-patient multiple-dose study
por: Almas, M, et al.
Publicado: (2013) -
Consistency vs. switching triptan treatment and headache-related disability: Results of the American migraine prevalence & prevention study
por: Buse, DC, et al.
Publicado: (2013)